2026 NPPES data Hematology & Oncology Physician NPI 1841426780 M.D.
Verify on CMS →

SUNG HO LEE, M.D.

Hematology & Oncology Physician in NYACK, New York. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
937
Medicare Part D claims · 198 beneficiaries · Hematology & Oncology Physician avg: 847
Generic prescribing
59%
generic claims · 41% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
75/100
▼ 8 pts below national avg 83.1 · [object Object]
Industry payments
$1.2K
53 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

SUNG HO LEE, M.D. reported a CMS MIPS final score of 75/100 — below the 83.1 national average — and filed 937 Medicare Part D claims in 2023.

75/100
MIPS score · -8 vs avg
937
Part D claims, 2023
59%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

SUNG HO LEE, M.D.'s MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

75 15th percentile higher than 15% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). This entry sits in this band. 80–90: 129,887 scored providers (27%). Above this entry. 90–100: 189,403 scored providers (40%). Above this entry. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

SUNG HO LEE, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about SUNG HO LEE, M.D.?

Below national average

NPI registry status

Active

Issued 06/05/2009

NPI 1841426780

Primary specialty

Hematology & Oncology Physician

Mid-sized

11,215 US NPIs in this specialty

Medicare Part D claims

937 11% vs specialty avg

2023 prescription claims

Specialty avg: 847

MIPS final score

75/100 8.099999999999994% pts

Above neutral band

vs 83.1 national avg

Specialty distribution in New York

How Hematology & Oncology Physician compares to other specialties among New York providers

New York providers

Hematology & Oncology Physician share within New York

1. Hematology & Oncology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Hematology & Oncology Physician share within New York

Medicare quality performance — MIPS

SUNG HO LEE, M.D.'s 2023 MIPS final score plotted against the Hematology & Oncology Physician national average

Below national average
MIPS Final Score
75/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Hematology & Oncology Physician) — 75/100 vs national avg 83.1

0%100%National avg83%75%
MIPS final score (Hematology & Oncology Physician) — 75/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

SUNG HO LEE, M.D. appears in the CMS NPPES registry as a Hematology & Oncology Physician provider holding M.D. credentials at 160 N MIDLAND AVE, NYACK, NY, 10960, with a listed phone of (845) 480-7440. NPI 1841426780 was issued on 06/05/2009. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what LEE most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 937 prescription claims written by this provider, covering 198 Medicare beneficiaries and totaling roughly $2.4 million in drug spend, split 41% brand-name and 59% generic by claim count, with an opioid prescribing rate of 3.8%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 75/100 for the 2023 performance year, compared with the national average of 83.1.

Hematology & Oncology Physician is a mid-sized specialty nationwide, with 11,215 enrolled providers across 54 states and an average of 847 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

160 N MIDLAND AVE
NYACK, NY 10960

Provider Details

NPI 1841426780
Specialty Hematology & Oncology Physician
Credentials M.D.
Gender Male
NPI Issued 06/05/2009

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

75
Final Score
Avg: 83.1

Reporting: Group practice

Hospital and facility affiliations

Facilities where SUNG HO LEE, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

WHITE PLAINS MEDICAL DIAGNOSTIC SERVICES, PC
NYACK, NY

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for SUNG HO LEE, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$1.2K

Largest payer

PFIZER INC.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — New York NYSBPMC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 — they are NOT specific to SUNG HO LEE, M.D.. To verify SUNG HO LEE, M.D.'s current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

312
Total board actions, New York 2023
Across 302 cases
3.12
Actions per 1,000 licensees
New York statewide rate
probation
Most common action type
89 cases

NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Above average

SUNG HO LEE, M.D. — brand share 41.0%
Specialty average (est.)

41% brand-name claims vs 59% generic, on 937 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

937
Total Claims
$2.4M
Total Drug Cost
198
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
1,484
Total Day Supply
41,140
Brand vs Generic
41% brand / 59% generic
Brand Drug Cost
$2.3M
Generic Drug Cost
$123K
Opioid Claims
36 (3.8% rate)
Antibiotic Claims
34

Patient Demographics

Average Patient Age
73.7 years
Avg HCC Risk Score
2.00
Gender Split
65% female / 35% male
Age Distribution
<65: 26, 65-74: 75, 75-84: 73, 85+: 24

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What SUNG HO LEE, M.D. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Eliquis
Apixaban
167
Anastrozole
129
Imbruvica
Ibrutinib
50
Hydroxyurea
37
Xarelto
Rivaroxaban
35
Gammaplex
Immun Glob G(Igg)/Gly/Iga 0-50
30
Oxycodone-Acetaminophen
Oxycodone Hcl/Acetaminophen
30
Revlimid
Lenalidomide
30
Pantoprazole Sodium
26
Letrozole
24

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Hematology & Oncology Physician Overview

How SUNG HO LEE, M.D. fits within the Hematology & Oncology Physician landscape nationally.

11,215
Hematology & Oncology Physician Providers in US
54
States with Hematology & Oncology Physician
847
Avg Claims per Provider

SUNG HO LEE, M.D.'s 937 claims are above the specialty average of 847.

Nearby Hematology & Oncology Physician Providers in New York

Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as LEE.

Compare Hematology & Oncology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is SUNG HO LEE, M.D.'s specialty?
SUNG HO LEE, M.D. specializes in Hematology & Oncology Physician and practices in NYACK, New York. Credentials: M.D..
How much does SUNG HO LEE, M.D. prescribe under Medicare Part D?
In 2023, SUNG HO LEE, M.D. wrote 937 Medicare Part D claims totaling $2.4M in drug costs for 198 beneficiaries.
What is SUNG HO LEE, M.D.'s Medicare quality score?
SUNG HO LEE, M.D. has a CMS MIPS Final Score of 75/100. The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is SUNG HO LEE, M.D. located?
SUNG HO LEE, M.D. is located at 160 N MIDLAND AVE, NYACK, NY, 10960. Phone: (845) 480-7440.
What is SUNG HO LEE, M.D.'s NPI number?
SUNG HO LEE, M.D.'s National Provider Identifier (NPI) is 1841426780, issued on 06/05/2009.
Does SUNG HO LEE, M.D. prescribe more brand-name or generic drugs?
SUNG HO LEE, M.D.'s prescribing is 41% brand-name and 59% generic drugs by claim count, with $2.3M in brand drug costs.
Does SUNG HO LEE, M.D. prescribe opioids?
Yes, SUNG HO LEE, M.D. had 36 opioid claims in 2023 with an opioid prescribing rate of 3.8%.
How many Hematology & Oncology Physician providers are there in the US?
There are 11,215 Hematology & Oncology Physician providers across 54 states in the US. The average Hematology & Oncology Physician provider writes 847 Medicare Part D claims per year.
What drugs does SUNG HO LEE, M.D. prescribe most often?
Based on 2023 Medicare Part D data, SUNG HO LEE, M.D.'s most frequently prescribed drugs include Eliquis, Anastrozole, Imbruvica. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does SUNG HO LEE, M.D. accept Medicare?
SUNG HO LEE, M.D. appears in CMS Medicare data with 937 Part D claims and 198 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify SUNG HO LEE, M.D.'s credentials?
SUNG HO LEE, M.D.'s NPI is 1841426780 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology